CancerConsultants™ Begins Syndicating Spanish Cancer Content to Internet Destinations

Ketchum, ID — August 22, 2002 —, the leading online cancer information provider, has enhanced its consumer Web site by offering comprehensive cancer information in Spanish. was founded in order to assist patients and their families in accessing current cancer treatment information to ensure that they receive high quality treatment and gain access to the newest cancer drugs/treatment strategies through the clinical trials process. Since 1998, has provided comprehensive, disease-specific cancer information to patients and their families at

As a bilingual site, will reach a growing Hispanic population in the U.S., as well as Spanish-speaking consumers in Latin America and Europe. According to the 2000 census, the Hispanic population in the U.S. grew 58% to reach 35 million people during the 1990s, becoming the nation’s largest minority group. Furthermore, the U.S. Department of Commerce estimates that Internet access among Hispanics has grown 171% since 1997, compared to only 123% for the general U.S. population. Almost 50% of Hispanics regularly access the Internet. By providing comprehensive cancer information in Spanish, ensures that this growing population has access to the most current treatment information.

In addition to providing content in Spanish to, will be licensing the Spanish content to hospitals and doctors’ offices. Currently, over 400,000 seekers of cancer information view’s syndicated content on leading hospital and physician practice Web sites that include Florida Hospital, UCLA, the MedStar and Methodist Health Systems and leading oncology practices such as Wilshire Oncology Medical Group in Los Angeles, The West Clinic in Memphis, and Tennessee Oncology in Nashville. The Oncology Hematology Group of South Florida, the leading private practice in Miami, will be the first to introduce bilingual cancer information to their patients.

“We are pleased to offer this service to our consumers,” Charles Weaver, CEO, said. “By implementing a bilingual platform, we enhance the interaction between healthcare providers and their constituents. Furthermore, we have guaranteed that even more consumers have access to valuable cancer information.”